The Cancer Research UK Cambridge Centre Podcast12 Marras 2025

Why patient and public involvement and engagement is important and what it means to those involved

Have you ever thought about getting involved in research as a patient or supporter? In this episode, Ellie Wolmark talks to the incredible members of the Women⁺s Cancers Programme Patient and Public Involvement and Engagement (PPIE) Group about how they are involved in our research, why they think involvement is so important, and what it means to them to be a part of the group. Not only do they share their stories and thoughts, but they also offer huge insight into their disease and the research surrounding it. They talk about how they can help and make an impact, not just for themselves and each other, but also for patients of the future. Their involvement is about making things easier, supporting quicker diagnoses, and helping to shape better, more personalised treatments. The episode is incredibly uplifting. You will hear how empowering they find being part of the group and engaging with research. They are a shining example of how knowledge is power. Their support for one another, and for the researchers through the ups and downs of this disease, gives real hope for a better future. Further information: -Find out more about the DEMO Project at https://ovarian.org.uk/our-research/improve-uk/demo-uk/ -Join the Wellcome Connecting Science course on 'The Power of Patient Advocacy in Genomics: Influencing Research, Clinical Practice and Decision Making' at https://www.futurelearn.com/courses/the-power-of-patient-advocacy-in-genomics-influencing-research-clinical-practice-and-decision-making

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(67)

The association between radioresistance and tumour evolution

Is a tumour's ability to evolve and adapt over time linked to why it becomes resistant to radiotherapy? And if so, what can we do to overcome this radioresistance? In this episode, Dr Christopher Jon...

22 Loka 202545min

Using AI to mathematically model the progression of glioblastoma

Can we use artificial intelligence (AI) to predict where a brain tumour might recur at the point of first diagnosis in order to pre-emptively treat it to stop recurrence? Dr Francesca Cozzi (a PhD s...

8 Loka 202528min

Studying the tumour microenvironment

Could the environment around a cancer tumour hold the key to better treatments? In this episode, PhD students Emily Lythgoe and Ellie Bunce from the University of Cambridge discuss their research int...

24 Syys 202532min

Building a tissue time machine

What if a time machine could be built, not from metal but from human tissue, to help us understand cancer and how it responds to treatment? Dr Alecia-Jane Twigger, Dr Akanksha Anand, Dr Kui Hua, Dr P...

10 Syys 202545min

Using AI in the screening and treatment of kidney cancer

Have you ever wondered how artificial intelligence (AI) is used in research in a healthcare setting? Rebecca Wray and Bill McGough, two PhD students at the University of Cambridge, both use AI in diff...

27 Elo 202533min

Using AI to detect stomach cancer during endoscopy

How can artificial intelligence (AI) support both cancer research and healthcare more generally? Anoushka Harit (University of Cambridge) and Dr Zhongtian Sun (University of Kent) join today's episode...

13 Elo 202547min

Ask me anything about... cachexia research and management

What do you most want to know about pancreatic cancer and cancer-associated cachexia? In this special episode, we bring you a recording of a live 'Ask Me Anything (AMA)' event hosted by the CRUK Camb...

30 Heinä 202544min